Home/Filings/4/0001437749-18-007489
4//SEC Filing

Reynolds Brett 4

Accession 0001437749-18-007489

CIK 0000894237other

Filed

Apr 22, 8:00 PM ET

Accepted

Apr 23, 5:08 PM ET

Size

13.3 KB

Accession

0001437749-18-007489

Insider Transaction Report

Form 4
Period: 2018-04-20
Reynolds Brett
Sr. Vice President and CFO
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2018-04-23$2.82/sh33,000$93,0600 total
    Exercise: $1.03From: 2016-06-29Exp: 2023-06-29Commn Stock (33,000 underlying)
  • Disposition to Issuer

    Common Stock

    2018-04-23$3.85/sh100,458$386,7630 total
  • Disposition to Issuer

    Stock Option (Right toBuy)

    2018-04-23$2.97/sh150,000$445,4850 total
    Exercise: $0.88From: 2016-06-13Exp: 2023-06-13Common Stock (150,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2018-04-23$2.20/sh226,027$497,2590 total
    Exercise: $1.65From: 2017-05-19Exp: 2027-05-19Common Stock (226,027 underlying)
  • Disposition from Tender

    Common Stock

    2018-04-20$3.85/sh81,405$313,409100,458 total
Footnotes (3)
  • [F1]On April 20, 2018, these shares were purchased in a tender offer for all of the issued and outstanding shares of common stock, par value $0.01 per share, of Cogentix Medical, Inc. (the Company") by Camden Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of LM US Parent, Inc. and Laborie Medical Technologies Canada ULC, pursuant to the Agreement and Plan of Merger dated as of March 11, 2018 (the "Merger Agreement").
  • [F2]Pursuant to the Merger Agreement, upon the effectiveness of the merger of Merger Sub with and into the Company (the "Merger"), these shares of restricted stock were cancelled and converted into the right to receive a cash payment of $3.85 per share, net to the reporting person in cash, without interest and less any applicable withholding taxes (the "Merger Consideration").
  • [F3]Pursuant to the Merger Agreement, upon effectiveness of the Merger, these options were cancelled and converted into the right to receive a cash payment equal to the product of (A) the total number of shares subject to such option and (B) the excess, if any, of the Merger Consideration over the exercise price per share.

Issuer

COGENTIX MEDICAL INC /DE/

CIK 0000894237

Entity typeother

Related Parties

1
  • filerCIK 0001323150

Filing Metadata

Form type
4
Filed
Apr 22, 8:00 PM ET
Accepted
Apr 23, 5:08 PM ET
Size
13.3 KB